mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |